摘要
目的：观察病毒性肺炎行喜炎平治疗的效果。方法回顾性分析2013年11月～2014年11月本院收治的92例病毒性肺炎患者的临床资料，按照随机数字表法分为两组，每组46例，对照组行利巴韦林治疗，研究组行喜炎平治疗，比较两组疗效及不良反应。结果对照组总有效率69.57%低于研究组93.48%，比较差异具统计学意义（P＜0.05）；对照组不良反应发生率13.04%，研究组为10.86%，比较差异无统计学意义（P＞0.05）。结论病毒性肺炎行喜炎平治疗效果确切，安全性高。
ObjectiveThe effect of viral pneumonia Xiyanping line treatment. Methods A retrospective analysis of 92 cases of clinical data in patients with viral pneumonia in November 2013 -2014 our hospital in November, according to a random number table is divided into two groups of 46 cases in the control group underwent ribavirin, Xiyanping study group underwent treatment efficacy and adverse reactions were compared.Results The control group, the total efifciency of 69.57% 93.48% lower than the study group, a statisticaly signiifcant difference （P 〈0.05）; incidence of adverse reactions 13.04% in the control group, the study group was 10.86%, the difference was not statisticaly signiifcant （P〉0.05）.Conclusion Viral pneumonia treatment line Xiyanping exact, safe.
出处
《中国继续医学教育》
2015年第6期256-257,共2页
China Continuing Medical Education
